Clinical Trial Update: Topiramate and Prolonged Exposure [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for topiramate in PTSD with comorbid Alcohol Use Disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD and Alcohol Use Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-11-18